Work

A Tailor-Made Guanidine Ionizable Lipid as a Bifunctional mRNA Carrier and Nitric Oxide Production Inhibitor

Year: 2026
Type: article
Abstract: Lipid nanoparticles (LNPs) are the leading clinical platform for mRNA delivery, yet their capacity to trigger macrophage-driven inflammatory responses remains a fundamental barrier to therapeutic safety and efficacy. Here, we introduce a design principle in which a tailor-made nitric oxide (NO) inhibitory motif is embedded directly into the ionizable lipid, creating a single molecular scaffold that simultaneously delivers mRNA and suppresses macrophage inflammation. Screening of a focused acyl-guanidine library in LPS-induced peritoneal macrophages identified G9 as a potent NO inhibitor and reprogrammed macrophage polarization from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype. Conjugation of the G9 headgroup to a lipid tail yielded G9-1, an NO-inhibitory ionizable lipid that retains anti-inflammatory activity and preferentially delivers mRNA to pulmonary vascular endothelial cells and alveolar macrophages in vivo. In a murine model of acute lung injury (ALI), G9-1 LNPs loaded with IL-10 mRNA reduce pulmonary immune cell infiltration, suppress inflammatory cytokine production, and attenuate systemic inflammation. These results establish NO inhibition as an actionable molecular design principle for intrinsically anti-inflammatory LNPs and position G9-1 as a dual-function ionizable lipid for safer and more effective mRNA therapeutics.
Language: English
Open Access status: green
OpenAlex ID: W7160553166
FWCI:
Cites: 59
Cited by:
Related to: 10